Infrared light instrument, x-ray imaging may improve optical mammography

A newly developed imaging instrument which may improve the sensitivity of optical mammography will be shown by Italian researchers at the OSA Biophotonics Congress: Biomedical Optics meeting this April in Hollywood, Florida, according to a press release from the Optical Society.  

Optical imaging is ideal in conjunction with x-rays to diagnose or monitor areas of the body that should avoid high exposure to ionizing radiation while providing efficient and accurate information and potential for use in pre-surgical chemotherapy.  

“This technique (optical mammography) is able to provide information on the outcome of chemotherapy just weeks after beginning treatment, or possibly even sooner," said co-author Edoardo Ferocino, PhD, from the Polytechnic University of Milan in Milan, Italy, according to a prepared statement.  

The new instrument will increase the sensitivity of optical mammography by as much as 1,000-fold, according to the press release, and can measure blood volume, oxygenation or collagen content in areas suspicious of breast cancer initially indicated by an x-ray exam. According to the release, the instrument replaces two photomultiplier tubes of existing instruments with an eight-channel probe containing silicon photomultipliers and a multichannel time-to-digital converter.

Find the full release below: 

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.